Refine my results

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

D'Addario, G. ; Rauch, D. ; Stupp, R. ; Pless, M. ; Stahel, R. ; Mach, N. ; Jost, L. ; Widmer, L. ; Tapia, C. ; Bihl, M. ; Mayer, M. ; Ribi, K. ; Lerch, S. ; Bubendorf, L. ; Betticher, D. C.

In: Annals of Oncology, 2007, vol. 19, no. 4, p. 739-745